Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, P.
Right arrow Articles by Godtfredsen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, P.
Right arrow Articles by Godtfredsen, J.

Stroke, Vol 17, 622-626, Copyright © 1986 by American Heart Association


ARTICLES

Embolic complications in paroxysmal atrial fibrillation

P Petersen and J Godtfredsen

The incidence of embolic complications among 426 patients with initial paroxysmal atrial fibrillation (PAF) was analysed. A distinct clustering of emboli was seen at the time of onset of PAF. After transition to chronic atrial fibrillation (CAF), which developed in 141 patients (33.1%), the incidence of emboli was seen to rise to a new level several times higher than the incidence level for patients with PAF. Also in this group a distinct clustering of emboli was seen during the first year after transition to CAF. On this background it is suggested that patients with PAF may benefit from treatment with anti- arrhythmic agents in order to prevent the development of CAF and that anticoagulants for stroke prevention seems especially desirable in atrial fibrillation (AF) of recent onset.


This article has been cited by other articles:


Home page
Eur Heart JHome page
R. Nieuwlaat, T. Dinh, S. B. Olsson, A. J. Camm, A. Capucci, R. G. Tieleman, G. Y.H. Lip, H. J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
Eur. Heart J., April 1, 2008; 29(7): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker
Corticosteroids and the risk of atrial fibrillation.
Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Mehra, E. J. Benjamin, E. Shahar, D. J. Gottlieb, R. Nawabit, H. L. Kirchner, J. Sahadevan, and S. Redline
Association of Nocturnal Arrhythmias with Sleep-disordered Breathing: The Sleep Heart Health Study
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Capucci, M. Santini, L. Padeletti, M. Gulizia, G. Botto, G. Boriani, R. Ricci, S. Favale, F. Zolezzi, N. Di Belardino, et al.
Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1913 - 1920.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker
Drug-induced atrial fibrillation
J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2117 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Manasse, P.G. Colombo, A. Barbone, P. Braidotti, G. Bulfamante, M. Roincalli, and R. Gallotti
Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablation
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
G.Y.H. Lip and F.L. L. S. Hee
Paroxysmal atrial fibrillation
QJM, December 1, 2001; 94(12): 665 - 678.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. G. Hart, L. A. Pearce, R. M. Rothbart, J. H. McAnulty, R. W. Asinger, J. L. Halperin, and for the Stroke Prevention in Atrial Fibrillation I
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 183 - 187.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone
Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience
Europace, January 1, 2000; 2(2): 119 - 126.
[Abstract] [PDF]


Home page
HeartHome page
M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al.
Thromboembolism after atrioventricular node ablation and pacing: long term follow up
Heart, October 1, 1999; 82(4): 494 - 498.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.-L. Medvedowsky, and A. Sebaoun
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France : The ALFA Study
Circulation, June 15, 1999; 99(23): 3028 - 3035.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. H. Eckman, R. H. Falk, and S. G. Pauker
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Arch Intern Med, August 10, 1998; 158(15): 1669 - 1677.
[Abstract] [Full Text]


Home page
StrokeHome page
H.-J. Lin, P. A. Wolf, E. J. Benjamin, A. J. Belanger, and R. B. D'Agostino
Newly Diagnosed Atrial Fibrillation and Acute Stroke : The Framingham Study
Stroke, September 1, 1995; 26(9): 1527 - 1530.
[Abstract] [Full Text]


Home page
NEJMHome page
W. J. Manning, D. I. Silverman, S. Gordon, H. M. Krumholz, and P. S. Douglas
Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi
N. Engl. J. Med., March 18, 1993; 328(11): 750 - 755.
[Abstract] [Full Text]


Home page
Vasc MedHome page
J. L Halperin
Prevention of embolism in atrial fibrillation
Vascular Medicine, September 1, 1991; 2(2): 111 - 119.
[PDF]